Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jul;36(7):1344-1354.
doi: 10.1038/s41433-020-01330-y. Epub 2021 Jan 21.

Refractory full thickness macular hole: current surgical management

Affiliations
Review

Refractory full thickness macular hole: current surgical management

Rino Frisina et al. Eye (Lond). 2022 Jul.

Erratum in

Abstract

This review aims to collect the proposed surgical techniques for treating full thickness macular hole (FTMH) refractory to pars plana vitrectomy and internal limiting membrane (ILM) peeling and to analyse and compare anatomical and functional outcomes in order to evaluate their efficacy. The articles were grouped according to the surgical techniques used. Refractory FTMH closure rate and best-corrected visual acuity (BCVA) gain were the two analysed parameters. Thirty-six articles were selected. Ten surgical technique subgroups were defined: autologous platelet concentrate (APC); lens capsular flap transplantation (LCFT); autologous free ILM flap transplantation (free ILM flap); enlargement of ILM peeling, macular hole hydrodissection (MHH), autologous retinal graft (ARG), silicon oil (SO), human amniotic membrane (hAM), perifoveal relaxing retinotomy, arcuate temporal retinotomy. Refractory FTMH closure rate was similar among subgroups, not significant heterogeneity emerged (p = 0.176). BCVA gain showed a significant dependence on surgical technique (p < 0.0001), significant heterogeneity among subgroups emerged (p < 0.0001). Three sets of surgical technique subgroups with a homogeneous BCVA gain were defined: high BCVA gain (hAM); intermediate BCVA gain (APC, ARG, LCFT, MHH, SO); low BCVA gain (free ILM flap, enlargement of peeling, arcuate temporal retinotomy). In terms of visual recovery, the most efficient technique for treating refractory FTMH is hAM, lens capsular flap and APC that allow to obtain better functional outcomes than free ILM flap. MHH, ARG, perifoveal relaxing and arcuate temporal retinotomy require complex and unjustified surgical manoeuvres in view of the surgical alternatives with overlapping anatomical and functional results.

难治性全层黄斑裂孔的手术治疗现状: 摘要: 本综述旨在总结玻璃体切除术和内界膜剥离术在处理难治性全层黄斑裂孔(FTMH)中的手术技巧, 分析并比较术后解剖和功能的不同, 以评估其疗效。本文根据已有的手术技术进行分组。以难治性FTMH的闭合率和最佳矫正视力(BCVA)的提高为2个分析指标。本综述共纳入36篇文献。手术技术分为10个亚组: 自体血小板浓缩(APC)、晶状体囊膜瓣移植(LCFT)、自体游离ILM瓣移植(游离ILM瓣)、ILM扩大剥离、黄斑裂孔水分离(MHH)、自体视网膜移植(ARG)、硅油(SO)、人羊膜(hAM)移植、中心凹周围区松解视网膜切开术、弧形颞侧视网膜切开术。各亚组间难治性FTMH闭合率相似, 未出现明显的异质性(p < 0.176)。最佳矫正视力的获益与手术技术有显著的相关性(p < 0.0001), 各亚组间也存在明显的异质性(p < 0.0001)。各种手术技术根据BCVA的获益定义为三个亚组: 高BCVA获益(hAM)、中等BCVA获益(APC、ARG、LCFT、MHH、SO)和低BCVA获益(游离ILM皮瓣、ILM扩大剥离、弧形颞侧视网膜切开术)。就视力恢复而言, 治疗难治性FTMH最有效的技术是hAM。与游离ILM皮瓣相比, LCF和APC可获得更佳的功能性恢复。针对各种手术方案具有重叠交叉的解剖和功能结果, MHH、ARG、中心凹周围区松解和弧形颞侧视网膜切开术需要复杂和未得到验证的手术操作。.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1. Postoperative tomographic foveal patterns.
Tomographic foveal patterns after surgically induced closure of full thickness macular hole (FTMH). a Restoration of foveal contour (dashed line) with integrity of outer retinal layers (ORL) (white arrows) equivalent to Imai’s “type U” and Kang’s “type 1”. b Thinned foveal floor with irregular foveal contour (dashed line) and interruption of ORL (white arrows), equivalent to Imai’s “type V” and Kang’s “type 1”. Patterns of full thickness macular hole (FTMH) refractory to pars plana vitrectomy and internal limiting membrane (ILM) peeling. c Refractory FTMH with elevated edges (dashed line) and bared retinal pigment epithelium (RPE) (white arrow), equivalent to Hillenkamp’s “type with cuff”. d Refractory FTMH with flat edges (dashed line) and bared RPE (white arrow), equivalent to Imai’s “type W”, Kang’s “type 2” and Hillenkamp’s “type without a cuff”. Tomographic images from the database of the department of Ophthalmology of University of Padova, Italy.
Fig. 2
Fig. 2. Flow chart shows detailed information on the number of articles screened (No. 412), assessed for eligibility and excluded or included for review.
Thirty-six articles were divided on the basis of the proposed surgical technique into ten subgroups.
Fig. 3
Fig. 3. Forest plot from meta-analysis of weighted closure rate of refractory full thickness macular hole (FTMH) for all articles.
No significant difference in refractory FTMH closure rate among the 36 articles was detected.
Fig. 4
Fig. 4. Funnel plot of refractory full thickness macular hole (FTMH) closure rate.
Symmetrical funnel plot suggests a low grade of heterogeneity of FTMH closure rate between the 36 analysed articles.
Fig. 5
Fig. 5. Forest plot from meta-analysis of best-corrected visual acuity (BCVA) gain among the 32 analysed articles.
Significant difference in BCVA gain among the surgical technique subgroups was demonstrated.
Fig. 6
Fig. 6. Funnel plot of best-corrected visual acuity (BCVA) gain.
Asymmetrical funnel plot suggests the high grade of heterogeneity of BCVA gain among the analysed articles. Thirteen articles fall outside the CI95% corresponding to the circles with ID number.

Comment in

References

    1. Kelly NE, Wendel RT. Vitreous surgery for idiopathic macular holes: results of a pilot study. Arch Ophthalmol. 1991;109:654–9. doi: 10.1001/archopht.1991.01080050068031.. - DOI - PubMed
    1. Glaser BM, Michels RG, Kuppermann BD, Sjaarda RN, Pena RA. Transforming growth factor-beta 2 for the treatment of full-thickness macular holes. A prospective randomized study. Ophthalmology. 1992;99:1162–72. doi: 10.1016/s0161-6420(92)31837-8. - DOI - PubMed
    1. Liggett PE, Skolik DS, Horio B, Saito Y, Alfaro V, Mieler W. Human autologous serum for the treatment of full-thickness macular holes. A preliminary study. Ophthalmology. 1995;102:1071–6. doi: 10.1016/S0161-6420(95)30909-8.. - DOI - PubMed
    1. Korobelnik JF, Hannouche D, Belayachi N, Branger M, Guez JE, Hoang-Xuan T. Autologous platelet concentrate as an adjunct in macular hole healing: a pilot study. Ophthalmology. 1996;103:590–4. doi: 10.1016/s0161-6420(96)30648-9.. - DOI - PubMed
    1. Ezra E, Aylward WG, Gregor ZJ. Membranectomy and autologous serum for the retreatment of full-thickness macular holes. Arch Ophthalmol. 1997;115:1276–80. doi: 10.1001/archopht.1997.01100160446010.. - DOI - PubMed

LinkOut - more resources